Nanobiosensors for cardiac biomarker monitoring using electrochemical and optical detection

Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, with acute coronary syndrome (ACS) accounting for a large portion of both the clinical and economic burden. Sensitive and specific cardiac biomarkers that enable rapid diagnosis of ACS and associated intervention can therefore profoundly impact accordingly. A diverse array of in vitro diagnostics exists for the detection of myriad cardiac biomarkers, notably troponin, CK-MB, and myoglobin, each capable of fulfilling diagnostic and/or prognostic roles. Recent advances in electrochemical and optical nanobiosensors have enabled highly sensitive, rapid, and point-of-care detection of cardiac biomarkers. The integration of nanomaterials, including gold nanoparticles, graphene derivatives, carbon nanotubes, and quantum dots, has significantly improved analytical performance by enhancing sensitivity, specificity, and signal amplification. This review systematically summarizes recent developments in nanobiosensor platforms for troponin, CK-MB, and myoglobin detection, highlighting sensing mechanisms, analytical performance, clinical applicability, current challenges, and future translational opportunities.

Authors

Institutions

Publication Details

Journal
Discover Sensors
Published
2026-11-18
DOI
https://doi.org/10.1007/s44397-026-00094-6
Primary Topic
Electrochemical sensors and biosensors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nanobiosensors for cardiac biomarker monitoring using electrochemical and optical detection

Kumud Kant Awasthi, Yash Bhardwaj, Mahipal Singh Sankhla, Vicky Kapoor et al.
Discover Sensors
Electrochemical sensors and biosensors
article

Nanobiosensors for cardiac biomarker monitoring using electrochemical and optical detection

Kumud Kant Awasthi, Yash Bhardwaj, Mahipal Singh Sankhla, Vicky Kapoor, Rishi Ranjan Kumar, Garima Awasthi, Anjali Awasthi, Baljeet Yadav
article en

Abstract

Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, with acute coronary syndrome (ACS) accounting for a large portion of both the clinical and economic burden. Sensitive and specific cardiac biomarkers that enable rapid diagnosis of ACS and associated intervention can therefore profoundly impact accordingly. A diverse array of in vitro diagnostics exists for the detection of myriad cardiac biomarkers, notably troponin, CK-MB, and myoglobin, each capable of fulfilling diagnostic and/or prognostic roles. Recent advances in electrochemical and optical nanobiosensors have enabled highly sensitive, rapid, and point-of-care detection of cardiac biomarkers. The integration of nanomaterials, including gold nanoparticles, graphene derivatives, carbon nanotubes, and quantum dots, has significantly improved analytical performance by enhancing sensitivity, specificity, and signal amplification. This review systematically summarizes recent developments in nanobiosensor platforms for troponin, CK-MB, and myoglobin detection, highlighting sensing mechanisms, analytical performance, clinical applicability, current challenges, and future translational opportunities.

Discover SensorsVol. 2(1)
KR Mangalam University (IN), University of Rajasthan (IN)
Good health and well-being
Electrochemical sensors and biosensors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon